Genzyme, Industry Analysts Relieved By Particulars In Draft Consent Decree

Unveiling its first-quarter financial results, Genzyme reports significant year-over-year sales decreases for Cerezyme and Fabrazyme.

More from Archive

More from Pink Sheet